Literature DB >> 30659242

Clinical pathophysiology of thyroid eye disease: The Cone Model.

Paul Meyer1,2, Tilak Das3, Nima Ghadiri4, Rachna Murthy5,6, Sofia Theodoropoulou7.   

Abstract

The clinical features of thyroid eye disease are dictated by the orbit's compartmentalisation; particularly, the muscle cone, which is delimited by the rectus muscles, their inter-muscular septa and the posterior sclera. The cone is anchored to the orbit apex and contains the posterior globe, the muscle bellies, a fat pad, and the blood circulation, optic nerve, and CSF sheath. It is surrounded by mobile extraconal fat, retained by the orbital septum.Thyroid eye disease is caused by expansion of muscle bellies and fat within the cone. Mechanical properties of the cone determine that the disease partitions into three phases: circumferential expansion, with forward displacement of extraconal fat; axial elongation, with increasing cone pressure; impedance of posterior venous outflow, with cone oedema and venous flow reversal.Venous flow reversal can be observed in the conjunctival circulation. It is initially transient, accompanying rises in cone pressure caused by eye movements, but later becomes permanent. It is a useful clinical sign that locates diseased muscles and anticipates venous compressive crises.Strabismus arises when inflamed rectus muscles, swollen by hydrated glycosaminoglycans, lose contractility and compliance. The incomitance is moderated by increasing stiffness affecting all the rectus muscles, as they are stretched during cone expansion.Immunomodulation, which rapidly reduces cone volume, relieving muscle elongation and stiffness, may paradoxically unmask strabismus. However, ciclosporin A suppresses late post-inflammatory fibrosis and only 4 of 71 patients so-treated required strabismus surgery.The cone model also accounts for the variety of clinical presentations of thyroid eye disease.

Entities:  

Mesh:

Year:  2019        PMID: 30659242      PMCID: PMC6367424          DOI: 10.1038/s41433-018-0302-1

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  1 in total

Review 1.  Graves' eye disease: orbital compliance and other physical measurements.

Authors:  B R Frueh
Journal:  Trans Am Ophthalmol Soc       Date:  1984
  1 in total
  4 in total

Review 1.  Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.

Authors:  Vardaan Gupta; Christine L Hammond; Elisa Roztocil; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

2.  Thyroid Eye Disease.

Authors:  Jason Szelog; Hollister Swanson; Matthew C Sniegowski; David B Lyon
Journal:  Mo Med       Date:  2022 Jul-Aug

3.  Unusual onset of thyroid associated orbitopathy during pregnancy: case report and review of literature.

Authors:  Janos K Aranyosi; Tamas Deli; Annamaria Erdei; Geza Toth; Attila Jakab; Mariann Fodor; Endre V Nagy; Bernadett Ujhelyi
Journal:  BMC Endocr Disord       Date:  2020-12-15       Impact factor: 2.763

4.  Change of intraocular blood flow during treatment for thyroid eye disease.

Authors:  Masashi Mimura; Yuko Nishikawa; Keiko Inagaki; Yohei Sato; Yasushi Fujita; Don O Kikkawa
Journal:  Taiwan J Ophthalmol       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.